{{Rsnum
|rsid=7756935
|Gene=PLA2G7
|Chromosome=6
|position=46707288
|Orientation=plus
|GMAF=0.2071
|Gene_s=PLA2G7
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 60.2 | 38.9 | 0.9
| HCB | 73.7 | 24.8 | 1.5
| JPT | 80.5 | 18.6 | 0.9
| YRI | 50.7 | 42.5 | 6.8
| ASW | 52.6 | 42.1 | 5.3
| CHB | 73.7 | 24.8 | 1.5
| CHD | 77.1 | 19.3 | 3.7
| GIH | 72.3 | 21.8 | 5.9
| LWK | 35.5 | 50.9 | 13.6
| MEX | 65.5 | 32.8 | 1.7
| MKK | 38.5 | 49.4 | 12.2
| TSI | 54.9 | 37.3 | 7.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22003152
|Trait=None
|Title=Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies.
|RiskAllele=A
|Pval=1E-10
|OR=0.0270
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=21854539
|Title=Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes.
}}

{{PMID Auto
|PMID=23404648
|Title=An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease
|OA=1
}}

{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}